{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:25:57Z","timestamp":1792067157591,"version":"4.4.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00018-018-2933-6","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:14:43Z","timestamp":1540005283000},"page":"259-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["The master regulator FUBP1: its emerging role in normal cell function and malignant development"],"prefix":"10.1007","volume":"76","author":[{"given":"Lydie","family":"Debaize","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-9670","authenticated-orcid":false,"given":"Marie-B\u00e9reng\u00e8re","family":"Troadec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"2933_CR1","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1038\/onc.2012.350","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang J, Chen QM (2013) Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene 32:2907\u20132916","journal-title":"Oncogene"},{"key":"2933_CR2","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1016\/S0021-9258(17)44785-5","volume":"265","author":"MI Avigan","year":"1990","unstructured":"Avigan MI, Strober B, Levens D (1990) A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. J Biol Chem 265:18538\u201318545","journal-title":"J Biol Chem"},{"key":"2933_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1101\/gad.8.4.465","volume":"8","author":"R Duncan","year":"1994","unstructured":"Duncan R, Bazar L, Michelotti G et al (1994) A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 8:465\u2013480. https:\/\/doi.org\/10.1101\/gad.8.4.465","journal-title":"Genes Dev"},{"key":"2933_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jncimonographs\/lgn004","volume":"2008","author":"D Levens","year":"2008","unstructured":"Levens D (2008) How the c-myc promoter works and why it sometimes does not. JNCI Monogr 2008:41\u201343. https:\/\/doi.org\/10.1093\/jncimonographs\/lgn004","journal-title":"JNCI Monogr"},{"key":"2933_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/emboj.2011.11","volume":"30","author":"J Liu","year":"2011","unstructured":"Liu J, Chung H-J, Vogt M et al (2011) JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J 30:846\u2013858. https:\/\/doi.org\/10.1038\/emboj.2011.11","journal-title":"EMBO J"},{"key":"2933_CR6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/hep.23051","volume":"50","author":"M Malz","year":"2009","unstructured":"Malz M, Weber A, Singer S et al (2009) Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology 50:1130\u20131139. https:\/\/doi.org\/10.1002\/hep.23051","journal-title":"Hepatology"},{"key":"2933_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/hep.27218","volume":"60","author":"M Malz","year":"2014","unstructured":"Malz M, Bovet M, Samarin J et al (2014) Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma. Hepatology 60:1241\u20131250","journal-title":"Hepatology"},{"key":"2933_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/hep.23098","volume":"50","author":"U Rabenhorst","year":"2009","unstructured":"Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu M-L et al (2009) Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology 50:1121\u20131129. https:\/\/doi.org\/10.1002\/hep.23098","journal-title":"Hepatology"},{"key":"2933_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/nan.12088","volume":"40","author":"P Baumgarten","year":"2014","unstructured":"Baumgarten P, Harter PN, T\u00f6njes M et al (2014) Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p\/19q loss of heterozygosity: FUBP1 expression in human gliomas. Neuropathol Appl Neurobiol 40:205\u2013216. https:\/\/doi.org\/10.1111\/nan.12088","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2933_CR10","doi-asserted-by":"publisher","first-page":"e0169852","DOI":"10.1371\/journal.pone.0169852","volume":"12","author":"J Duan","year":"2017","unstructured":"Duan J, Bao X, Ma X et al (2017) Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and tumorigenesis of clear cell renal cell carcinoma. PLoS One 12:e0169852. https:\/\/doi.org\/10.1371\/journal.pone.0169852","journal-title":"PLoS One"},{"key":"2933_CR11","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1016\/j.bmc.2016.09.015","volume":"24","author":"S Hauck","year":"2016","unstructured":"Hauck S, Hiesinger K, Khageh Hosseini S et al (2016) Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitors. Bioorg Med Chem 24:5717\u20135729. https:\/\/doi.org\/10.1016\/j.bmc.2016.09.015","journal-title":"Bioorg Med Chem"},{"key":"2933_CR12","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/0008-5472.CAN-08-3338","volume":"69","author":"S Singer","year":"2009","unstructured":"Singer S, Malz M, Herpel E et al (2009) Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res 69:2234\u20132243. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3338","journal-title":"Cancer Res"},{"key":"2933_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.1210557","volume":"333","author":"C Bettegowda","year":"2011","unstructured":"Bettegowda C, Agrawal N, Jiao Y et al (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453\u20131455. https:\/\/doi.org\/10.1126\/science.1210557","journal-title":"Science"},{"key":"2933_CR14","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1007\/s13277-015-4263-8","volume":"37","author":"L Yang","year":"2016","unstructured":"Yang L, Zhu J, Zhang J et al (2016) Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression. Tumor Biol 37:4115\u20134126. https:\/\/doi.org\/10.1007\/s13277-015-4263-8","journal-title":"Tumor Biol"},{"key":"2933_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/mc.22114","volume":"54","author":"Z Ding","year":"2015","unstructured":"Ding Z, Liu X, Liu Y et al (2015) Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation. Mol Carcinog 54:405\u2013415. https:\/\/doi.org\/10.1002\/mc.22114","journal-title":"Mol Carcinog"},{"key":"2933_CR16","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.celrep.2015.05.038","volume":"11","author":"U Rabenhorst","year":"2015","unstructured":"Rabenhorst U, Thalheimer FB, Gerlach K et al (2015) Single-stranded DNA-binding transcriptional regulator FUBP1 is essential for fetal and adult hematopoietic stem cell self-renewal. Cell Rep 11:1847\u20131855. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.038","journal-title":"Cell Rep"},{"key":"2933_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.10.028","author":"W Zhou","year":"2016","unstructured":"Zhou W, Chung Y-J, Castellar ER et al (2016) Far upstream element binding protein plays a crucial role in embryonic development, hematopoiesis, and stabilizing MYC expression levels. Am J Pathol. https:\/\/doi.org\/10.1016\/j.ajpath.2015.10.028","journal-title":"Am J Pathol"},{"key":"2933_CR18","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1128\/MCB.16.5.2274","volume":"16","author":"R Duncan","year":"1996","unstructured":"Duncan R, Collins I, Tomonaga T et al (1996) A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP. Mol Cell Biol 16:2274\u20132282","journal-title":"Mol Cell Biol"},{"key":"2933_CR19","doi-asserted-by":"publisher","first-page":"31679","DOI":"10.1074\/jbc.271.49.31679","volume":"271","author":"T Davis-Smyth","year":"1996","unstructured":"Davis-Smyth T, Duncan RC, Zheng T et al (1996) The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J Biol Chem 271:31679\u201331687. https:\/\/doi.org\/10.1074\/jbc.271.49.31679","journal-title":"J Biol Chem"},{"key":"2933_CR20","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1128\/MCB.00754-06","volume":"26","author":"H-J Chung","year":"2006","unstructured":"Chung H-J, Liu J, Dundr M et al (2006) FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol 26:6584\u20136597. https:\/\/doi.org\/10.1128\/MCB.00754-06","journal-title":"Mol Cell Biol"},{"key":"2933_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wrna.1327","volume":"7","author":"P Briata","year":"2016","unstructured":"Briata P, Bordo D, Puppo M et al (2016) Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease. Wiley Interdiscip Rev RNA 7:227\u2013240. https:\/\/doi.org\/10.1002\/wrna.1327","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2933_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.molcel.2004.05.002","volume":"14","author":"R Gherzi","year":"2004","unstructured":"Gherzi R, Lee K-Y, Briata P et al (2004) A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell 14:571\u2013583. https:\/\/doi.org\/10.1016\/j.molcel.2004.05.002","journal-title":"Mol Cell"},{"key":"2933_CR23","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1093\/nar\/gkq1295","volume":"39","author":"B-H Gau","year":"2011","unstructured":"Gau B-H, Chen T-M, Shih Y-HJ, Sun HS (2011) FUBP3 interacts with FGF9 3\u2032 microsatellite and positively regulates FGF9 translation. Nucleic Acids Res 39:3582\u20133593. https:\/\/doi.org\/10.1093\/nar\/gkq1295","journal-title":"Nucleic Acids Res"},{"key":"2933_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1471-2407-8-369","volume":"8","author":"A Weber","year":"2008","unstructured":"Weber A, Kristiansen I, Johannsen M et al (2008) The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer 8:369. https:\/\/doi.org\/10.1186\/1471-2407-8-369","journal-title":"BMC Cancer"},{"key":"2933_CR25","doi-asserted-by":"publisher","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","volume":"46","author":"DR Zerbino","year":"2018","unstructured":"Zerbino DR, Achuthan P, Akanni W et al (2018) Ensembl 2018. Nucleic Acids Res 46:D754\u2013D761. https:\/\/doi.org\/10.1093\/nar\/gkx1098","journal-title":"Nucleic Acids Res"},{"key":"2933_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0168-9525(97)01103-7","volume":"13","author":"M Rebhan","year":"1997","unstructured":"Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997) GeneCards: integrating information about genes, proteins and diseases. Trends Genet TIG 13:163","journal-title":"Trends Genet TIG"},{"key":"2933_CR27","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1111\/j.1742-4658.2008.06411.x","volume":"275","author":"R Valverde","year":"2008","unstructured":"Valverde R, Edwards L, Regan L (2008) Structure and function of KH domains: structure and function of KH domains. FEBS J 275:2712\u20132726. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06411.x","journal-title":"FEBS J"},{"key":"2933_CR28","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1128\/JVI.01950-10","volume":"85","author":"H-L Chien","year":"2011","unstructured":"Chien H-L, Liao C-L, Lin Y-L (2011) FUSE binding protein 1 interacts with untranslated regions of japanese encephalitis virus RNA and negatively regulates viral replication. J Virol 85:4698\u20134706. https:\/\/doi.org\/10.1128\/JVI.01950-10","journal-title":"J Virol"},{"key":"2933_CR29","first-page":"2019","volume":"7","author":"Q Tang","year":"2014","unstructured":"Tang Q, Xia W, Ji Q et al (2014) Role of far upstream element binding protein 1 in colonic epithelial disruption during dextran sulphate sodium-induced murine colitis. Int J Clin Exp Pathol 7:2019\u20132031","journal-title":"Int J Clin Exp Pathol"},{"key":"2933_CR30","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/onc.2009.11","volume":"28","author":"M Jang","year":"2009","unstructured":"Jang M, Park BC, Kang S et al (2009) Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene. Oncogene 28:1529\u20131536","journal-title":"Oncogene"},{"key":"2933_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng1182","volume":"34","author":"MJ Kim","year":"2003","unstructured":"Kim MJ, Park B-J, Kang Y-S et al (2003) Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation. Nat Genet 34:330\u2013336. https:\/\/doi.org\/10.1038\/ng1182","journal-title":"Nat Genet"},{"key":"2933_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/embor.2011.140","volume":"12","author":"BS Atanassov","year":"2011","unstructured":"Atanassov BS, Dent SYR (2011) USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep 12:924\u2013930. https:\/\/doi.org\/10.1038\/embor.2011.140","journal-title":"EMBO Rep"},{"key":"2933_CR33","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck PV, Zhang B, Murray B et al (2015) PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res 43:D512\u2013D520. https:\/\/doi.org\/10.1093\/nar\/gku1267","journal-title":"Nucleic Acids Res"},{"key":"2933_CR34","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.1038\/onc.2016.151","volume":"35","author":"L Venturutti","year":"2016","unstructured":"Venturutti L, Cordo Russo RI, Rivas MA et al (2016) MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Oncogene 35:6189\u20136202. https:\/\/doi.org\/10.1038\/onc.2016.151","journal-title":"Oncogene"},{"key":"2933_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-017-0263-x","author":"D Zhao","year":"2017","unstructured":"Zhao D, Zhang Y, Song L (2017) MiR-16-1 targeted silences far upstream element binding protein 1 to advance the chemosensitivity to adriamycin in gastric cancer. Pathol Oncol Res POR. https:\/\/doi.org\/10.1007\/s12253-017-0263-x","journal-title":"Pathol Oncol Res POR"},{"key":"2933_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-62703-032-8_1","volume":"922","author":"AH Marceau","year":"2012","unstructured":"Marceau AH (2012) Functions of single-strand DNA-binding proteins in DNA replication, recombination, and repair. Methods Mol Biol Clifton NJ 922:1\u201321. https:\/\/doi.org\/10.1007\/978-1-62703-032-8_1","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"2933_CR37","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1128\/MCB.16.6.2656","volume":"16","author":"GA Michelotti","year":"1996","unstructured":"Michelotti GA, Michelotti EF, Pullner A et al (1996) Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol 16:2656\u20132669","journal-title":"Mol Cell Biol"},{"key":"2933_CR38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1128\/MCB.16.5.2350","volume":"16","author":"EF Michelotti","year":"1996","unstructured":"Michelotti EF, Michelotti GA, Aronsohn AI, Levens D (1996) Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 16:2350\u20132360","journal-title":"Mol Cell Biol"},{"key":"2933_CR39","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1073\/pnas.93.12.5830","volume":"93","author":"T Tomonaga","year":"1996","unstructured":"Tomonaga T, Levens D (1996) Activating transcription from single stranded DNA. Proc Natl Acad Sci USA 93:5830\u20135835","journal-title":"Proc Natl Acad Sci USA"},{"key":"2933_CR40","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1093\/emboj\/cdf352","volume":"21","author":"DT Braddock","year":"2002","unstructured":"Braddock DT (2002) Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: solution structure of a complex between hnRNP K KH3 and single-stranded DNA. EMBO J 21:3476\u20133485. https:\/\/doi.org\/10.1093\/emboj\/cdf352","journal-title":"EMBO J"},{"key":"2933_CR41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/4151051a","volume":"415","author":"DT Braddock","year":"2002","unstructured":"Braddock DT, Louis JM, Baber JL et al (2002) Structure and dynamics of KH domains from FBP bound to single-stranded DNA. Nature 415:1051\u20131056. https:\/\/doi.org\/10.1038\/4151051a","journal-title":"Nature"},{"key":"2933_CR42","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1021\/bi9021445","volume":"49","author":"H Hsiao","year":"2010","unstructured":"Hsiao H, Nath A, Lin C-Y et al (2010) Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR. Biochemistry (Mosc) 49:4620\u20134634. https:\/\/doi.org\/10.1021\/bi9021445","journal-title":"Biochemistry (Mosc)"},{"key":"2933_CR43","doi-asserted-by":"publisher","first-page":"18296","DOI":"10.1073\/pnas.0803279105","volume":"105","author":"LR Benjamin","year":"2008","unstructured":"Benjamin LR, Chung H-J, Sanford S et al (2008) Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein. Proc Natl Acad Sci 105:18296\u201318301","journal-title":"Proc Natl Acad Sci"},{"key":"2933_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky756","author":"L Debaize","year":"2018","unstructured":"Debaize L, Jakobczyk H, Avner S et al (2018) Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gky756","journal-title":"Nucleic Acids Res"},{"key":"2933_CR45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ et al (2015) MYC, metabolism, and cancer. Cancer Discov 5:1024\u20131039. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0507","journal-title":"Cancer Discov"},{"key":"2933_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) MYC on the Path to Cancer. Cell 149:22\u201335. https:\/\/doi.org\/10.1016\/j.cell.2012.03.003","journal-title":"Cell"},{"key":"2933_CR47","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/emboj\/19.5.1034","volume":"19","author":"L He","year":"2000","unstructured":"He L, Liu J, Collins I et al (2000) Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J 19:1034\u20131044. https:\/\/doi.org\/10.1093\/emboj\/19.5.1034","journal-title":"EMBO J"},{"key":"2933_CR48","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/0092-8674(93)90624-Y","volume":"75","author":"WJ Feaver","year":"1993","unstructured":"Feaver WJ, Svejstrup JQ, Bardwell L et al (1993) Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair. Cell 75:1379\u20131387. https:\/\/doi.org\/10.1016\/0092-8674(93)90624-Y","journal-title":"Cell"},{"key":"2933_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.8465201","volume":"260","author":"L Schaeffer","year":"1993","unstructured":"Schaeffer L, Roy R, Humbert S et al (1993) DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260:58\u201363. https:\/\/doi.org\/10.1126\/science.8465201","journal-title":"Science"},{"key":"2933_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm3350","volume":"13","author":"E Compe","year":"2012","unstructured":"Compe E, Egly J-M (2012) TFIIH: when transcription met DNA repair. Nat Rev Mol Cell Biol 13:343. https:\/\/doi.org\/10.1038\/nrm3350","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2933_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0092-8674(93)90140-L","volume":"73","author":"JD Parvin","year":"1993","unstructured":"Parvin JD, Sharp PA (1993) DNA topology and a minimal set of basal factors for transcription by RNA polymerase II. Cell 73:533\u2013540","journal-title":"Cell"},{"key":"2933_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0092-8674(94)90242-9","volume":"77","author":"JA Goodrich","year":"1994","unstructured":"Goodrich JA, Tjian R (1994) Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell 77:145\u2013156","journal-title":"Cell"},{"key":"2933_CR53","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1073\/pnas.96.7.3940","volume":"96","author":"DW Felsher","year":"1999","unstructured":"Felsher DW, Bishop JM (1999) Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA 96:3940\u20133944","journal-title":"Proc Natl Acad Sci USA"},{"key":"2933_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1097-2765(00)80428-1","volume":"5","author":"J Liu","year":"2000","unstructured":"Liu J, He L, Collins I et al (2000) The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell 5:331\u2013341. https:\/\/doi.org\/10.1016\/S1097-2765(00)80428-1","journal-title":"Mol Cell"},{"key":"2933_CR55","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/sj.emboj.7601101","volume":"25","author":"J Liu","year":"2006","unstructured":"Liu J, Kouzine F, Nie Z et al (2006) The FUSE\/FBP\/FIR\/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 25:2119\u20132130. https:\/\/doi.org\/10.1038\/sj.emboj.7601101","journal-title":"EMBO J"},{"key":"2933_CR56","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/0008-5472.CAN-04-4459","volume":"66","author":"K Matsushita","year":"2006","unstructured":"Matsushita K, Tomonaga T, Shimada H et al (2006) An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis. Cancer Res 66:1409\u20131417. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4459","journal-title":"Cancer Res"},{"key":"2933_CR57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.emboj.7601936","volume":"27","author":"GV Crichlow","year":"2008","unstructured":"Crichlow GV, Zhou H, Hsiao H et al (2008) Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition. EMBO J 27:277\u2013289. https:\/\/doi.org\/10.1038\/sj.emboj.7601936","journal-title":"EMBO J"},{"key":"2933_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/MCB.25.1.147-161.2005","volume":"25","author":"A Weber","year":"2005","unstructured":"Weber A, Liu J, Collins I, Levens D (2005) TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol 25:147\u2013161. https:\/\/doi.org\/10.1128\/MCB.25.1.147-161.2005","journal-title":"Mol Cell Biol"},{"key":"2933_CR59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jcb.20187","volume":"93","author":"CI Rubin","year":"2004","unstructured":"Rubin CI, Atweh GF (2004) The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93:242\u2013250. https:\/\/doi.org\/10.1002\/jcb.20187","journal-title":"J Cell Biochem"},{"key":"2933_CR60","first-page":"299","volume":"69","author":"SJ Mistry","year":"2002","unstructured":"Mistry SJ, Atweh GF (2002) Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J Med N Y 69:299\u2013304","journal-title":"Mt Sinai J Med N Y"},{"key":"2933_CR61","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1091\/mbc.E07-09-0894","volume":"19","author":"B Belletti","year":"2008","unstructured":"Belletti B, Nicoloso MS, Schiappacassi M et al (2008) Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 19:2003\u20132013. https:\/\/doi.org\/10.1091\/mbc.E07-09-0894","journal-title":"Mol Biol Cell"},{"key":"2933_CR62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.lungcan.2008.03.033","volume":"63","author":"R Kuner","year":"2009","unstructured":"Kuner R, Muley T, Meister M et al (2009) Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer Amst Neth 63:32\u201338. https:\/\/doi.org\/10.1016\/j.lungcan.2008.03.033","journal-title":"Lung Cancer Amst Neth"},{"key":"2933_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0092-8674(94)90290-9","volume":"78","author":"R Krumlauf","year":"1994","unstructured":"Krumlauf R (1994) Hox genes in vertebrate development. Cell 78:191\u2013201","journal-title":"Cell"},{"key":"2933_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/stem.140281","volume":"14","author":"HJ Lawrence","year":"1996","unstructured":"Lawrence HJ, Sauvageau G, Humphries RK, Largman C (1996) The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells Dayt Ohio 14:281\u2013291. https:\/\/doi.org\/10.1002\/stem.140281","journal-title":"Stem Cells Dayt Ohio"},{"key":"2933_CR65","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","volume":"90","author":"VC Broudy","year":"1997","unstructured":"Broudy VC (1997) Stem cell factor and hematopoiesis. Blood 90:1345\u20131364","journal-title":"Blood"},{"key":"2933_CR66","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1007\/s00018-004-4273-y","volume":"61","author":"Y Kitamura","year":"2004","unstructured":"Kitamura Y, Hirotab S (2004) Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci CMLS 61:2924\u20132931. https:\/\/doi.org\/10.1007\/s00018-004-4273-y","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2933_CR67","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3181\/00379727-213-44046","volume":"213","author":"AL Gartel","year":"1996","unstructured":"Gartel AL, Serfas MS, Tyner AL (1996) p21\u2013negative regulator of the cell cycle. Proc Soc Exp Biol Med 213:138\u2013149","journal-title":"Proc Soc Exp Biol Med"},{"key":"2933_CR68","first-page":"639","volume":"1","author":"AL Gartel","year":"2002","unstructured":"Gartel AL, Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1:639\u2013649","journal-title":"Mol Cancer Ther"},{"key":"2933_CR69","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1242\/jcs.027730","volume":"121","author":"G Soria","year":"2008","unstructured":"Soria G, Speroni J, Podhajcer OL et al (2008) p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. J Cell Sci 121:3271\u20133282. https:\/\/doi.org\/10.1242\/jcs.027730","journal-title":"J Cell Sci"},{"key":"2933_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-925","author":"U Dixit","year":"2014","unstructured":"Dixit U, Liu Z, Pandey AK et al (2014) Fuse binding protein antagonizes the transcription activity of tumor suppressor protein. BMC Cancer. https:\/\/doi.org\/10.1186\/1471-2407-14-925","journal-title":"BMC Cancer"},{"key":"2933_CR71","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1128\/JVI.00729-15","volume":"89","author":"U Dixit","year":"2015","unstructured":"Dixit U, Pandey AK, Liu Z et al (2015) FUSE binding protein 1 facilitates persistent hepatitis C virus replication in hepatoma cells by regulating tumor suppressor p53. J Virol 89:7905\u20137921. https:\/\/doi.org\/10.1128\/JVI.00729-15","journal-title":"J Virol"},{"key":"2933_CR72","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00439-18","author":"JR Frost","year":"2018","unstructured":"Frost JR, Mendez M, Soriano AM (2018) Adenovirus 5 E1A-mediated suppression of p53 via FUBP1. J Virol. https:\/\/doi.org\/10.1128\/jvi.00439-18","journal-title":"J Virol"},{"key":"2933_CR73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/BJ20031484","volume":"377","author":"G Sully","year":"2004","unstructured":"Sully G, Dean JLE, Wait R et al (2004) Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element\/poly(U)-binding\/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1). Biochem J 377:629\u2013639. https:\/\/doi.org\/10.1042\/BJ20031484","journal-title":"Biochem J"},{"key":"2933_CR74","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1128\/JVI.00064-08","volume":"82","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Harris D, Pandey VN (2008) The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus. J Virol 82:5761\u20135773. https:\/\/doi.org\/10.1128\/JVI.00064-08","journal-title":"J Virol"},{"key":"2933_CR75","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1073\/pnas.83.6.1670","volume":"83","author":"D Caput","year":"1986","unstructured":"Caput D, Beutler B, Hartog K et al (1986) Identification of a common nucleotide sequence in the 3\u2032-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670\u20131674","journal-title":"Proc Natl Acad Sci USA"},{"key":"2933_CR76","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1042\/bst0300952","volume":"30","author":"T Zhang","year":"2002","unstructured":"Zhang T, Kruys V, Huez G, Gueydan C (2002) AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans 30:952\u2013958. https:\/\/doi.org\/10.1042\/bst0300952","journal-title":"Biochem Soc Trans"},{"key":"2933_CR77","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/wrna.2","volume":"1","author":"Gherzi Roberto","year":"2010","unstructured":"Roberto Gherzi, Ching-Yi Chen, Michele Trabucchi et al (2010) The role of KSRP in mRNA decay and microRNA precursor maturation. Wiley Interdiscip Rev RNA 1:230\u2013239. https:\/\/doi.org\/10.1002\/wrna.2","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2933_CR78","doi-asserted-by":"publisher","first-page":"17350","DOI":"10.1074\/jbc.M114.554717","volume":"289","author":"AG Jacob","year":"2014","unstructured":"Jacob AG, Singh RK, Mohammad F et al (2014) The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 Pre-mRNA. J Biol Chem 289:17350\u201317364. https:\/\/doi.org\/10.1074\/jbc.M114.554717","journal-title":"J Biol Chem"},{"key":"2933_CR79","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1093\/nar\/gkv086","volume":"43","author":"J Miro","year":"2015","unstructured":"Miro J, Laaref AM, Rofidal V et al (2015) FUBP1: a new protagonist in splicing regulation of the DMD gene. Nucleic Acids Res 43:2378\u20132389. https:\/\/doi.org\/10.1093\/nar\/gkv086","journal-title":"Nucleic Acids Res"},{"key":"2933_CR80","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2015070836","author":"W Zheng","year":"2016","unstructured":"Zheng W, Shen F, Hu R et al (2016) Far upstream element-binding protein 1 binds the 3\u2032 untranslated region of PKD2 and suppresses its translation. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/asn.2015070836","journal-title":"J Am Soc Nephrol"},{"key":"2933_CR81","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/nar\/25.6.1281","volume":"25","author":"N Irwin","year":"1997","unstructured":"Irwin N, Baekelandt V, Goritchenko L, Benowitz LI (1997) Identification of two proteins that bind to a pyrimidine-rich sequence in the 3\u2032-untranslated region of GAP-43 mRNA. Nucleic Acids Res 25:1281\u20131288","journal-title":"Nucleic Acids Res"},{"key":"2933_CR82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/onc.2010.404","volume":"30","author":"ME Olanich","year":"2011","unstructured":"Olanich ME, Moss BL, Piwnica-Worms D et al (2011) Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene 30:77\u201386","journal-title":"Oncogene"},{"key":"2933_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-016-0073-9","author":"JK Box","year":"2016","unstructured":"Box JK, Paquet N, Adams MN et al (2016) Nucleophosmin: from structure and function to disease development. BMC Mol Biol. https:\/\/doi.org\/10.1186\/s12867-016-0073-9","journal-title":"BMC Mol Biol"},{"key":"2933_CR84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-5793(00)01320-X","volume":"470","author":"BY Williams","year":"2000","unstructured":"Williams BY, Hamilton SL, Sarkar HK (2000) The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain. FEBS Lett 470:207\u2013210. https:\/\/doi.org\/10.1016\/S0014-5793(00)01320-X","journal-title":"FEBS Lett"},{"key":"2933_CR85","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.biocel.2011.08.001","volume":"43","author":"Y Zheng","year":"2011","unstructured":"Zheng Y, Miskimins WK (2011) Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int J Biochem Cell Biol 43:1641\u20131648. https:\/\/doi.org\/10.1016\/j.biocel.2011.08.001","journal-title":"Int J Biochem Cell Biol"},{"key":"2933_CR86","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1093\/nar\/gkr682","volume":"39","author":"P-N Huang","year":"2011","unstructured":"Huang P-N, Lin J-Y, Locker N et al (2011) Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res 39:9633\u20139648. https:\/\/doi.org\/10.1093\/nar\/gkr682","journal-title":"Nucleic Acids Res"},{"key":"2933_CR87","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.foodchem.2011.03.022","volume":"128","author":"F-J Tsai","year":"2011","unstructured":"Tsai F-J, Lin C-W, Lai C-C et al (2011) Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem 128:312\u2013322. https:\/\/doi.org\/10.1016\/j.foodchem.2011.03.022","journal-title":"Food Chem"},{"key":"2933_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005959","author":"C-T Hung","year":"2016","unstructured":"Hung C-T, Kung Y-A, Li M-L et al (2016) Additive promotion of viral internal ribosome entry site-mediated translation by far upstream element-binding protein 1 and an enterovirus 71-induced cleavage product. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1005959","journal-title":"PLoS Pathog"},{"key":"2933_CR89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/nar\/gkn901","volume":"37","author":"J-Y Lin","year":"2009","unstructured":"Lin J-Y, Li M-L, Shih S-R (2009) Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res 37:47\u201359. https:\/\/doi.org\/10.1093\/nar\/gkn901","journal-title":"Nucleic Acids Res"},{"key":"2933_CR90","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1101\/gad.11.8.1023","volume":"11","author":"H Min","year":"1997","unstructured":"Min H, Turck CW, Nikolic JM, Black DL (1997) A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 11:1023\u20131036","journal-title":"Genes Dev"},{"key":"2933_CR91","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1097-2765(01)00311-2","volume":"8","author":"E Labourier","year":"2001","unstructured":"Labourier E, Adams MD, Rio DC (2001) Modulation of P-Element Pre-mRNA Splicing by a Direct Interaction between PSI and U1 snRNP 70\u00a0K Protein. Mol Cell 8:363\u2013373. https:\/\/doi.org\/10.1016\/S1097-2765(01)00311-2","journal-title":"Mol Cell"},{"key":"2933_CR92","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1101\/gr.473902","volume":"12","author":"J Rappsilber","year":"2002","unstructured":"Rappsilber J, Ryder U, Lamond AI, Mann M (2002) Large-Scale proteomic analysis of the human spliceosome. Genome Res 12:1231\u20131245. https:\/\/doi.org\/10.1101\/gr.473902","journal-title":"Genome Res"},{"key":"2933_CR93","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Pan Q, Shai O, Lee LJ et al (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413\u20131415. https:\/\/doi.org\/10.1038\/ng.259","journal-title":"Nat Genet"},{"key":"2933_CR94","doi-asserted-by":"publisher","first-page":"E2687","DOI":"10.1073\/pnas.1310607110","volume":"110","author":"H Li","year":"2013","unstructured":"Li H, Wang Z, Zhou X et al (2013) Far upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repression. Proc Natl Acad Sci 110:E2687\u2013E2695. https:\/\/doi.org\/10.1073\/pnas.1310607110","journal-title":"Proc Natl Acad Sci"},{"key":"2933_CR95","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003707","author":"CL Will","year":"2011","unstructured":"Will CL, L\u00fchrmann R (2011) Spliceosome structure and function. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a003707","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2933_CR96","doi-asserted-by":"publisher","first-page":"E4604","DOI":"10.1073\/pnas.1800260115","volume":"115","author":"J Wang","year":"2018","unstructured":"Wang J, Schultz PG, Johnson KA (2018) Mechanistic studies of a small-molecule modulator of SMN2 splicing. Proc Natl Acad Sci USA 115:E4604\u2013E4612. https:\/\/doi.org\/10.1073\/pnas.1800260115","journal-title":"Proc Natl Acad Sci USA"},{"key":"2933_CR97","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s000180050273","volume":"55","author":"DA Freedman","year":"1999","unstructured":"Freedman DA, Wu L, Levine AJ (1999) Functions of the MDM2 oncoprotein. Cell Mol Life Sci CMLS 55:96\u2013107. https:\/\/doi.org\/10.1007\/s000180050273","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2933_CR98","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AEH Emery","year":"2002","unstructured":"Emery AEH (2002) The muscular dystrophies. Lancet Lond Engl 359:687\u2013695. https:\/\/doi.org\/10.1016\/S0140-6736(02)07815-7","journal-title":"Lancet Lond Engl"},{"key":"2933_CR99","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1101\/gr.229757.117","volume":"28","author":"FXR Sutandy","year":"2018","unstructured":"Sutandy FXR, Ebersberger S, Huang L et al (2018) In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors. Genome Res 28:699\u2013713. https:\/\/doi.org\/10.1101\/gr.229757.117","journal-title":"Genome Res"},{"key":"2933_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.02.013","author":"I Hwang","year":"2018","unstructured":"Hwang I, Cao D, Na Y et al (2018) Far upstream element-binding protein 1 regulates LSD1 alternative splicing to promote terminal differentiation of neural progenitors. Stem Cell Rep. https:\/\/doi.org\/10.1016\/j.stemcr.2018.02.013","journal-title":"Stem Cell Rep"},{"key":"2933_CR101","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro-Oncol 16:896\u2013913. https:\/\/doi.org\/10.1093\/neuonc\/nou087","journal-title":"Neuro-Oncol"},{"key":"2933_CR102","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1078-0432.1119.11.3","volume":"11","author":"V Barbashina","year":"2005","unstructured":"Barbashina V, Salazar P, Holland EC et al (2005) Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res Off J Am Assoc Cancer Res 11:1119\u20131128","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2933_CR103","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00401-012-0993-5","volume":"123","author":"F Sahm","year":"2012","unstructured":"Sahm F, Koelsche C, Meyer J et al (2012) CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathol (Berl) 123:853\u2013860. https:\/\/doi.org\/10.1007\/s00401-012-0993-5","journal-title":"Acta Neuropathol (Berl)"},{"key":"2933_CR104","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/modpathol.2013.165","volume":"27","author":"AK-Y Chan","year":"2014","unstructured":"Chan AK-Y, Pang JC-S, Chung NY-F et al (2014) Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors. Mod Pathol Off J US Can Acad Pathol Inc 27:332\u2013342. https:\/\/doi.org\/10.1038\/modpathol.2013.165","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"2933_CR105","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/nejmoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RGW, Cancer Genome Atlas Research Network et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498. https:\/\/doi.org\/10.1056\/nejmoa1402121","journal-title":"N Engl J Med"},{"key":"2933_CR106","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458\u2013468. https:\/\/doi.org\/10.1038\/ng.3273","journal-title":"Nat Genet"},{"key":"2933_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0422-z","author":"K Aihara","year":"2017","unstructured":"Aihara K, Nagae G (2017) Genetic and epigenetic stability of oligodendrogliomas at recurrence. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-017-0422-z","journal-title":"Acta Neuropathol Commun"},{"key":"2933_CR108","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta-Pardo E et al (2018) Comprehensive characterization of cancer driver genes and mutations. Cell 173:371\u2013385. https:\/\/doi.org\/10.1016\/j.cell.2018.02.060","journal-title":"Cell"},{"key":"2933_CR109","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.2995","volume":"226","author":"S Yip","year":"2012","unstructured":"Yip S, Butterfield YS, Morozova O et al (2012) Concurrent CIC mutations, IDH mutations, and 1p\/19q loss distinguish oligodendrogliomas from other cancers. J Pathol 226:7\u201316. https:\/\/doi.org\/10.1002\/path.2995","journal-title":"J Pathol"},{"key":"2933_CR110","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/2159-8290.CD-14-0892","volume":"5","author":"J Chen","year":"2015","unstructured":"Chen J, Hackett CS, Zhang S et al (2015) The genetics of splicing in neuroblastoma. Cancer Discov 5:380\u2013395. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0892","journal-title":"Cancer Discov"},{"key":"2933_CR111","doi-asserted-by":"publisher","first-page":"e1001229","DOI":"10.1371\/journal.pbio.1001229","volume":"10","author":"RK Bradley","year":"2012","unstructured":"Bradley RK, Merkin J, Lambert NJ, Burge CB (2012) Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution. PLoS Biol 10:e1001229. https:\/\/doi.org\/10.1371\/journal.pbio.1001229","journal-title":"PLoS Biol"},{"key":"2933_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1535-6108(02)00091-0","volume":"2","author":"F Bartel","year":"2002","unstructured":"Bartel F, Taubert H, Harris LC (2002) Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2:9\u201315. https:\/\/doi.org\/10.1016\/S1535-6108(02)00091-0","journal-title":"Cancer Cell"},{"key":"2933_CR113","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1016\/j.yexcr.2009.07.017","volume":"315","author":"RK Singh","year":"2009","unstructured":"Singh RK, Tapia-Santos A, Bebee TW, Chandler DS (2009) Conserved sequences in the final intron of MDM2 are essential for the regulation of alternative splicing of MDM2 in response to stress. Exp Cell Res 315:3419\u20133432. https:\/\/doi.org\/10.1016\/j.yexcr.2009.07.017","journal-title":"Exp Cell Res"},{"key":"2933_CR114","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1074\/jbc.M305966200","volume":"279","author":"HA Steinman","year":"2004","unstructured":"Steinman HA, Burstein E, Lengner C et al (2004) An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. J Biol Chem 279:4877\u20134886. https:\/\/doi.org\/10.1074\/jbc.M305966200","journal-title":"J Biol Chem"},{"key":"2933_CR115","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","volume":"23","author":"M Seiler","year":"2018","unstructured":"Seiler M, Peng S, Agrawal AA et al (2018) Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep 23:282\u2013296. https:\/\/doi.org\/10.1016\/j.celrep.2018.01.088","journal-title":"Cell Rep"},{"key":"2933_CR116","doi-asserted-by":"publisher","first-page":"e1920","DOI":"10.1038\/cddis.2015.258","volume":"6","author":"Z-H Liu","year":"2015","unstructured":"Liu Z-H, Hu J-L, Liang J-Z et al (2015) Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression. Cell Death Dis 6:e1920. https:\/\/doi.org\/10.1038\/cddis.2015.258","journal-title":"Cell Death Dis"},{"key":"2933_CR117","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1186\/1471-2407-14-837","volume":"14","author":"Z P\u00e9nzv\u00e1lt\u00f3","year":"2014","unstructured":"P\u00e9nzv\u00e1lt\u00f3 Z, L\u00e1nczky A, L\u00e9n\u00e1rt J et al (2014) MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer. BMC Cancer 14:837. https:\/\/doi.org\/10.1186\/1471-2407-14-837","journal-title":"BMC Cancer"},{"key":"2933_CR118","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.3892\/ol.2017.6978","volume":"14","author":"J Zhang","year":"2017","unstructured":"Zhang J, Xiong X, Hua X et al (2017) Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin. Oncol Lett 14:5819\u20135824. https:\/\/doi.org\/10.3892\/ol.2017.6978","journal-title":"Oncol Lett"},{"key":"2933_CR119","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1111\/j.1440-1746.2007.05293.x","volume":"23","author":"MC Yu","year":"2008","unstructured":"Yu MC, Yuan J-M, Lu SC (2008) Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 23:S92\u2013S97. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05293.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2933_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","volume":"15","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Yoon SK, Lencioni R (2010) The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15:14\u201322. https:\/\/doi.org\/10.1634\/theoncologist.2010-S4-14","journal-title":"Oncologist"},{"key":"2933_CR121","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000012024","volume":"57","author":"S Kawate","year":"1999","unstructured":"Kawate S, Fukusato T, Ohwada S et al (1999) Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression. Oncology 57:157\u2013163. https:\/\/doi.org\/10.1159\/000012024","journal-title":"Oncology"},{"key":"2933_CR122","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557\u20132576. https:\/\/doi.org\/10.1053\/j.gastro.2007.04.061","journal-title":"Gastroenterology"},{"key":"2933_CR123","first-page":"1719","volume":"53","author":"H Murakami","year":"1993","unstructured":"Murakami H, Sanderson ND, Nagy P et al (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53:1719\u20131723","journal-title":"Cancer Res"},{"key":"2933_CR124","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.510290410","volume":"29","author":"DB Zimonjic","year":"1999","unstructured":"Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC (1999) Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatol Baltimore, MD 29:1208\u20131214. https:\/\/doi.org\/10.1002\/hep.510290410","journal-title":"Hepatol Baltimore, MD"},{"key":"2933_CR125","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hep.22033","volume":"47","author":"C Schlaeger","year":"2008","unstructured":"Schlaeger C, Longerich T, Schiller C et al (2008) Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatol Baltimore, MD 47:511\u2013520. https:\/\/doi.org\/10.1002\/hep.22033","journal-title":"Hepatol Baltimore, MD"},{"key":"2933_CR126","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1002\/pmic.200800322","volume":"8","author":"RM Zubaidah","year":"2008","unstructured":"Zubaidah RM, Tan GS, Tan SBE et al (2008) 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics 8:5086\u20135096. https:\/\/doi.org\/10.1002\/pmic.200800322","journal-title":"Proteomics"},{"key":"2933_CR127","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbrc.2017.08.008","volume":"491","author":"H Wen","year":"2017","unstructured":"Wen H, Ma H, Li P et al (2017) Expression of far upstream element-binding protein 1 correlates with c-Myc expression in sacral chordomas and is associated with tumor progression and poor prognosis. Biochem Biophys Res Commun 491:1047\u20131054. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.008","journal-title":"Biochem Biophys Res Commun"},{"key":"2933_CR128","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/ijo.2016.3541","volume":"49","author":"X Xiong","year":"2016","unstructured":"Xiong X, Zhang J, Liang W et al (2016) Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells. Int J Oncol 49:623\u2013628","journal-title":"Int J Oncol"},{"key":"2933_CR129","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/bjc.1998.565","volume":"78","author":"I Bi\u00e8che","year":"1998","unstructured":"Bi\u00e8che I, Lachkar S, Becette V et al (1998) Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 78:701\u2013709","journal-title":"Br J Cancer"},{"key":"2933_CR130","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/path.4588","volume":"237","author":"B M\u00fcller","year":"2015","unstructured":"M\u00fcller B, Bovet M, Yin Y et al (2015) Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells. J Pathol 237:390\u2013401. https:\/\/doi.org\/10.1002\/path.4588","journal-title":"J Pathol"},{"key":"2933_CR131","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2350-12-156","volume":"12","author":"AG Brisbin","year":"2011","unstructured":"Brisbin AG, Asmann YW, Song H et al (2011) Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. BMC Med Genet 12:156. https:\/\/doi.org\/10.1186\/1471-2350-12-156","journal-title":"BMC Med Genet"},{"key":"2933_CR132","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.lungcan.2009.02.017","volume":"66","author":"MC Boelens","year":"2009","unstructured":"Boelens MC, Kok K, van der Vlies P et al (2009) Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer Amsterdam Netherlands 66:372\u2013378. https:\/\/doi.org\/10.1016\/j.lungcan.2009.02.017","journal-title":"Lung Cancer Amsterdam Netherlands"},{"key":"2933_CR133","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bjc.6602448","volume":"92","author":"P Moinzadeh","year":"2005","unstructured":"Moinzadeh P, Breuhahn K, St\u00fctzer H, Schirmacher P (2005) Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade\u2014results of an explorative CGH meta-analysis. Br J Cancer 92:935\u2013941. https:\/\/doi.org\/10.1038\/sj.bjc.6602448","journal-title":"Br J Cancer"},{"key":"2933_CR134","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.2741\/3461","volume":"14","author":"K Matsushita","year":"2009","unstructured":"Matsushita K, Tomonaga T, Kajiwara T et al (2009) c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy. Front Biosci Landmark Ed 14:3401\u20133408","journal-title":"Front Biosci Landmark Ed"},{"key":"2933_CR135","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","volume":"87","author":"I Saito","year":"1990","unstructured":"Saito I, Miyamura T, Ohbayashi A et al (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci 87:6547\u20136549","journal-title":"Proc Natl Acad Sci"},{"key":"2933_CR136","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/PL00000939","volume":"58","author":"ST Shi","year":"2001","unstructured":"Shi ST, Lai MM (2001) Hepatitis C viral RNA: challenges and promises. Cell Mol Life Sci CMLS 58:1276\u20131295. https:\/\/doi.org\/10.1007\/PL00000939","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2933_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5762301","volume":"2017","author":"J Wesely","year":"2017","unstructured":"Wesely J, Steiner M, Schntgen F et al (2017) Delayed mesoderm and erythroid differentiation of murine embryonic stem cells in the absence of the transcriptional regulator FUBP1. Stem Cells Int 2017:1\u201312. https:\/\/doi.org\/10.1155\/2017\/5762301","journal-title":"Stem Cells Int"},{"key":"2933_CR138","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.313104","volume":"18","author":"A Wilson","year":"2004","unstructured":"Wilson A, Murphy MJ, Oskarsson T et al (2004) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18:2747\u20132763. https:\/\/doi.org\/10.1101\/gad.313104","journal-title":"Genes Dev"},{"key":"2933_CR139","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ni.1839","volume":"11","author":"L Reavie","year":"2010","unstructured":"Reavie L, Gatta GD, Crusio K et al (2010) Hematopoietic stem cell differentiation regulated by a single ubiquitin ligase: substrate complex. Nat Immunol 11:207\u2013215. https:\/\/doi.org\/10.1038\/ni.1839","journal-title":"Nat Immunol"},{"key":"2933_CR140","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/sj.onc.1205400","volume":"21","author":"B Hoffman","year":"2002","unstructured":"Hoffman B, Amanullah A, Shafarenko M, Liebermann DA (2002) The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21:3414\u20133421. https:\/\/doi.org\/10.1038\/sj.onc.1205400","journal-title":"Oncogene"},{"key":"2933_CR141","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1128\/MCB.8.4.1614","volume":"8","author":"SO Freytag","year":"1988","unstructured":"Freytag SO (1988) Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0\/G1. Mol Cell Biol 8:1614\u20131624","journal-title":"Mol Cell Biol"},{"key":"2933_CR142","first-page":"17","volume":"211","author":"B Hoffman","year":"1996","unstructured":"Hoffman B, Liebermann DA, Selvakumaran M, Nguyen HQ (1996) Role of c-myc in myeloid differentiation, growth arrest and apoptosis. Curr Top Microbiol Immunol 211:17\u201327","journal-title":"Curr Top Microbiol Immunol"},{"key":"2933_CR143","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert K, Takenaka K, Lechman ER et al (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17:1086\u20131093. https:\/\/doi.org\/10.1038\/nm.2415","journal-title":"Nat Med"},{"key":"2933_CR144","doi-asserted-by":"publisher","DOI":"10.1177\/1947601910377495","author":"MD Delgado","year":"2010","unstructured":"Delgado MD, Le\u00f3n J (2010) Myc roles in hematopoiesis and leukemia. Genes Cancer. https:\/\/doi.org\/10.1177\/1947601910377495","journal-title":"Genes Cancer"},{"key":"2933_CR145","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1634\/stemcells.2004-0117","volume":"23","author":"J Lennartsson","year":"2005","unstructured":"Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R (2005) Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells 23:16\u201343. https:\/\/doi.org\/10.1634\/stemcells.2004-0117","journal-title":"Stem Cells"},{"key":"2933_CR146","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exphem.2016.09.005","volume":"45","author":"RR Weidemann","year":"2017","unstructured":"Weidemann RR, Behrendt R, Schoedel KB et al (2017) Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice. Exp Hematol 45:45\u201355. https:\/\/doi.org\/10.1016\/j.exphem.2016.09.005","journal-title":"Exp Hematol"},{"key":"2933_CR147","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN et al (2015) Mutations driving CLL and their evolution in progression and relapse. Nature 526:525\u2013530. https:\/\/doi.org\/10.1038\/nature15395","journal-title":"Nature"},{"key":"2933_CR148","doi-asserted-by":"publisher","first-page":"64071","DOI":"10.18632\/oncotarget.11773","volume":"27","author":"CM Lindqvist","year":"2016","unstructured":"Lindqvist CM, Lundmark A, Nordlund J et al (2016) Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. Oncotarget 27:64071\u201364088. https:\/\/doi.org\/10.18632\/oncotarget.11773","journal-title":"Oncotarget"},{"key":"2933_CR149","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/ijc.30263","volume":"139","author":"P Klener","year":"2016","unstructured":"Klener P, Fronkova E, Berkova A et al (2016) Mantle cell lymphoma-variant Richter syndrome: detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years: mantle cell lymphoma-variant Richter syndrome. Int J Cancer 139:2252\u20132260. https:\/\/doi.org\/10.1002\/ijc.30263","journal-title":"Int J Cancer"},{"key":"2933_CR150","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1021\/jm0497803","volume":"47","author":"JR Huth","year":"2004","unstructured":"Huth JR, Yu L, Collins I et al (2004) NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem 47:4851\u20134857. https:\/\/doi.org\/10.1021\/jm0497803","journal-title":"J Med Chem"},{"key":"2933_CR151","doi-asserted-by":"publisher","first-page":"e68226","DOI":"10.1371\/journal.pone.0068226","volume":"8","author":"SL-K Au","year":"2013","unstructured":"Au SL-K, Wong CC-L, Lee JM-F et al (2013) EZH2-mediated H3K27me3 is involved in epigenetic repression of deleted in liver cancer 1 in human cancers. PLoS One 8:e68226. https:\/\/doi.org\/10.1371\/journal.pone.0068226","journal-title":"PLoS One"},{"key":"2933_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/srep12999","author":"Y-F Lv","year":"2015","unstructured":"Lv Y-F, Yan G-N, Meng G (2015) Enhancer of zeste homolog two silencing inhibits tumor growth and lung metastasis in osteosarcoma. Sci Rep. https:\/\/doi.org\/10.1038\/srep12999","journal-title":"Sci Rep"},{"key":"2933_CR153","first-page":"63","volume":"5","author":"KM Niforou","year":"2008","unstructured":"Niforou KM, Anagnostopoulos AK, Vougas K et al (2008) The proteome profile of the human osteosarcoma U2OS cell line. Cancer Genom Proteom 5:63\u201378","journal-title":"Cancer Genom Proteom"},{"key":"2933_CR154","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally S, Dhanasekaran SM, Zhou M et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624\u2013629. https:\/\/doi.org\/10.1038\/nature01075","journal-title":"Nature"},{"key":"2933_CR155","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1073\/pnas.1933744100","volume":"100","author":"CG Kleer","year":"2003","unstructured":"Kleer CG, Cao Q, Varambally S et al (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100:11606\u201311611. https:\/\/doi.org\/10.1073\/pnas.1933744100","journal-title":"Proc Natl Acad Sci USA"},{"key":"2933_CR156","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bcp.2017.10.003","volume":"146","author":"S Khageh Hosseini","year":"2017","unstructured":"Khageh Hosseini S, Kolterer S, Steiner M et al (2017) Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE. Biochem Pharmacol 146:53\u201362. https:\/\/doi.org\/10.1016\/j.bcp.2017.10.003","journal-title":"Biochem Pharmacol"},{"key":"2933_CR157","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou X, Edmonson MN, Wilkinson MR et al (2016) Exploring genomic alteration in pediatric cancer using protein paint. Nat Genet 48:4\u20136. https:\/\/doi.org\/10.1038\/ng.3466","journal-title":"Nat Genet"},{"key":"2933_CR158","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N et al (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603\u2013607. https:\/\/doi.org\/10.1038\/nature11003","journal-title":"Nature"},{"key":"2933_CR159","doi-asserted-by":"publisher","first-page":"e45950","DOI":"10.1371\/journal.pone.0045950","volume":"7","author":"A Idbaih","year":"2012","unstructured":"Idbaih A, Ducray F, Dehais C et al (2012) SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS One 7:e45950. https:\/\/doi.org\/10.1371\/journal.pone.0045950","journal-title":"PLoS One"},{"key":"2933_CR160","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2217\/cns.15.32","volume":"4","author":"DP Cahill","year":"2015","unstructured":"Cahill DP, Louis DN, Cairncross JG (2015) Molecular background of oligodendroglioma: 1p\/19q, IDH, TERT, CIC and FUBP1. CNS Oncol 4:287\u2013294. https:\/\/doi.org\/10.2217\/cns.15.32","journal-title":"CNS Oncol"},{"key":"2933_CR161","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11060-015-1741-1","volume":"122","author":"L Erdem-Eraslan","year":"2015","unstructured":"Erdem-Eraslan L, Heijsman D, de Wit M et al (2015) Tumor-specific mutations in low-frequency genes affect their functional properties. J Neurooncol 122:461\u2013470. https:\/\/doi.org\/10.1007\/s11060-015-1741-1","journal-title":"J Neurooncol"},{"key":"2933_CR162","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjx056","author":"L Zhang","year":"2017","unstructured":"Zhang L, Liu Y, Wang M (2017) EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients. J Mol Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjx056","journal-title":"J Mol Cell Biol"},{"key":"2933_CR163","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3892\/ijo.2013.1782","volume":"42","author":"J Ma","year":"2013","unstructured":"Ma J, Chen M, Xia S-K et al (2013) Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression. Int J Oncol 42:1093\u20131104","journal-title":"Int J Oncol"},{"key":"2933_CR164","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hep.28357","volume":"63","author":"J Samarin","year":"2016","unstructured":"Samarin J, Laketa V, Malz M et al (2016) PI3K\/AKT\/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells. Hepatology 63:813\u2013826. https:\/\/doi.org\/10.1002\/hep.28357","journal-title":"Hepatology"},{"key":"2933_CR165","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1159\/000355659","volume":"36","author":"F Zhang","year":"2013","unstructured":"Zhang F, Tian Q, Wang Y (2013) Far upstream element-binding protein 1 (FUBP1) is overexpressed in human gastric cancer tissue compared to non-cancerous tissue. Onkologie 36:650\u2013655. https:\/\/doi.org\/10.1159\/000355659","journal-title":"Onkologie"},{"key":"2933_CR166","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4149\/neo_2014_065","volume":"61","author":"MY Jia","year":"2014","unstructured":"Jia MY, Wang YJ (2014) Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue. Neoplasma 61:533\u2013540. https:\/\/doi.org\/10.4149\/neo_2014_065","journal-title":"Neoplasma"},{"key":"2933_CR167","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-005-7556-1","volume":"275","author":"J-P Gagn\u00e9","year":"2005","unstructured":"Gagn\u00e9 J-P, Gagn\u00e9 P, Hunter JM et al (2005) Proteome profiling of human epithelial ovarian cancer cell line TOV-112D. Mol Cell Biochem 275:25\u201355","journal-title":"Mol Cell Biochem"},{"key":"2933_CR168","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-0352","author":"Q Zhong","year":"2017","unstructured":"Zhong Q, Liu Z, Lin Z-R et al (2017) The RARS-MADlLl fusion gene induces cancer stem cell-like properties and therapeutic resistance in nasopharyngeal carcinoma. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.ccr-17-0352","journal-title":"Clin Cancer Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-018-2933-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2933-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2933-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T05:46:03Z","timestamp":1662270363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-018-2933-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2933"],"URL":"https:\/\/doi.org\/10.1007\/s00018-018-2933-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"11 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}